← Human Trials & Peer-Reviewed Studies

Understanding Cognition, Oxytocin, and Pain in Elders (UCOPE): protocol for a double-blinded cross-over trial in chronic knee osteoarthritis pain

Plain-language guide to PMID 39920837 (2025): randomized and double-blind clinical study of Oxytocin in 80 participants, chronic pain: fibromyalgia & crps.

Key Facts

PMID
39920837
Journal
Trials
Year
2025
Study type
Clinical Study
Authors
Cruz-Almeida Y et al. (6 authors)
DOI
10.1186/s13063-024-08715-4

What This Study Did, in Plain Language

What Was Tested

Researchers studied Oxytocin in the context of chronic pain: fibromyalgia & crps in this clinical study publication.

The primary aims of the study are to examine preliminary analgesic effects of a chronic OT intervention in community-dwelling older individuals with chronic knee osteoarthritis pain.

Why It Was Studied

Osteoarthritis (OA) is the leading cause of disability among older adults with the knee being the most affected joint.

Specifically, there is an urgent need to develop better analgesics for individuals with OA-related pain, since currently used analgesics frequently fail to provide adequate relief or must be discontinued owing to adverse effects.

Who Took Part

The abstract describes 80 participants taking part.

By PubMed's age tags, the people studied were middle-aged adults and older adults, both men and women.

Primary study outcomes include preliminary changes in pain intensity and interference as well as multi-modal assessment batteries including circulating biomarkers and neuroimaging measures.

How the Study Was Run

The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.

Because people in this Oxytocin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Oxytocin.

Some participants received a placebo instead of Oxytocin, giving a reference point.

In the crossover set-up each of the participants took both Oxytocin and the comparison in turn, acting as their own control.

What Was Measured

Topics PubMed links to this paper include Oxytocin, Osteoarthritis, Knee, Cognition, Chronic Pain, Pain Measurement, Arthralgia and Randomized Controlled Trials as Topic.

Author keywords: Aging, Brain, Disability and Knee osteoarthritis pain.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Oxytocin in 80 participants in people with chronic pain: fibromyalgia & crps.

Results are reported in around 2 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2025 (Trials), a journal based in England.

More context: the Oxytocin compound page, Chronic pain: fibromyalgia & CRPS research.

Our Notes on the Compound

Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.